Jagasia; Ravi
Patent Applications and Registrations
Patent applications and USPTO patent grants for Jagasia; Ravi.The latest application filed is for "antisense oligonucleotide for targeting progranulin".
Company Profile
6.16.23
- Jagasia; Ravi - Basel CH
- JAGASIA; Ravi - Riehen Basel-City
- JAGASIA; Ravi - Loerrach DE
- Jagasia; Ravi - Lorrach DE
Patent Activity
| Patent | Date |
|---|---|
| Antisense Oligonucleotide for Targeting Progranulin App 20220204973 - Jagasia; Ravi ; et al. | 2022-06-30 |
| Oligonucleotides For Inducing Paternal Ube3a Expression App 20220146496 - Costa; Veronica ; et al. | 2022-05-12 |
| Oligonucleotides for inducing paternal UBE3A expression Grant 11,320,421 - Costa , et al. May 3, 2 | 2022-05-03 |
| E3 Ubiquitin Ligase (ube3a) Protein Targets App 20220091137 - Costa; Veronica ; et al. | 2022-03-24 |
| Oligonucleotides Targeting Rna Binding Protein Sites App 20220033818 - WANG; Congwei ; et al. | 2022-02-03 |
| Oligonucleotide Agonists Targeting Progranulin App 20210388357 - JAGASIA; Ravi ; et al. | 2021-12-16 |
| Antisense Oligonucleotides Targeting Tia1 App 20210261961 - COSTA; Veronica ; et al. | 2021-08-26 |
| Oligonucleotides For Inducing Paternal Ube3a Expression App 20200348286 - Costa; Veronica ; et al. | 2020-11-05 |
| Oligonucleotides for inducing paternal UBE3A expression Grant 10,739,332 - Costa , et al. A | 2020-08-11 |
| Oligonucleotides for inducing paternal UBE3A expression Grant 10,718,753 - Costa , et al. | 2020-07-21 |
| Oligonucleotides For Inducing Paternal Ube3a Expression App 20200057052 - Costa; Veronica ; et al. | 2020-02-20 |
| Oligonucleotides for inducing paternal UBE3A expression Grant 10,494,633 - Costa , et al. De | 2019-12-03 |
| Oligonucleotides For Inducing Paternal Ube3a Expression App 20190310244 - Costa; Veronica ; et al. | 2019-10-10 |
| N-phenyl-lactam derivatives capable of stimulating neurogenesis and their use in the treatment of neurological disorders Grant 9,714,239 - Jakob-Roetne , et al. July 25, 2 | 2017-07-25 |
| Oligonucleotides For Inducing Paternal Ube3a Expression App 20170191064 - Costa; Veronica ; et al. | 2017-07-06 |
| 1,7-naphthyridine derivatives Grant 9,688,675 - Ceccarelli , et al. June 27, 2 | 2017-06-27 |
| Pyrido[4,3-B]pyrazine-2-carboxamides as neurogenic agents for the treatment of neurodegenerative disorders Grant 9,670,206 - Jagasia , et al. June 6, 2 | 2017-06-06 |
| Substituted 1,6-naphthyridines Grant 9,657,014 - Ceccarelli , et al. May 23, 2 | 2017-05-23 |
| Isoquinoline derivatives Grant 9,586,903 - Ceccarelli , et al. March 7, 2 | 2017-03-07 |
| Piperazino[1,2-a]indol-1-ones and [1,4]diazepino[1,2-a]indol-one Grant 9,586,966 - Jagasia , et al. March 7, 2 | 2017-03-07 |
| Conversion Of Somatic Cells To Induced Reprogrammed Neural Stem Cells (irnscs) App 20160369234 - Christensen; Klaus ; et al. | 2016-12-22 |
| N-phenyl-lactam Derivatives Capable Of Stimulating Neurogenesis And Their Use In The Treatment Of Neurological Disorders App 20160326150 - Jakob-Roetne; Roland ; et al. | 2016-11-10 |
| Indole-carboxamides Grant 9,464,049 - Jagasia , et al. October 11, 2 | 2016-10-11 |
| Benzisoxazoles Grant 9,440,962 - Ceccarelli , et al. September 13, 2 | 2016-09-13 |
| Pyrido[4,3-b]pyrazine-2-carboxamides As Neurogenic Agents For The Treatment Of Neurodegenerative Disorders App 20160251355 - Jagasia; Ravi ; et al. | 2016-09-01 |
| Indole-carboxamides App 20160185721 - Jagasia; Ravi ; et al. | 2016-06-30 |
| Benzimidazoles as CNS active agents Grant 9,365,550 - Ceccarelli , et al. June 14, 2 | 2016-06-14 |
| 1,7-naphthyridine Derivatives App 20160137643 - Ceccarelli; Simona M. ; et al. | 2016-05-19 |
| Imidazopyridine derivatives Grant 9,315,502 - Ceccarelli , et al. April 19, 2 | 2016-04-19 |
| Conversion of somatic cells to induced reprogrammed neural stem cells (irNSCs) Grant 9,297,025 - Christensen , et al. March 29, 2 | 2016-03-29 |
| Piperazino[1,2-a]indol-1-ones and [1,4]diazepino[1,2-a]indol-1-one Grant 9,284,321 - Ceccarelli , et al. March 15, 2 | 2016-03-15 |
| Isoquinoline Derivatives App 20160046583 - Ceccarelli; Simona M. ; et al. | 2016-02-18 |
| Piperazino[1,2-a]indol-1-ones and [1,4]diazepino[1,2-a]indol-one App 20160016963 - Jagasia; Ravi ; et al. | 2016-01-21 |
| Benzisoxazoles App 20150259334 - Ceccarelli; Simona M. ; et al. | 2015-09-17 |
| Imidazopyridine Derivatives App 20150259341 - Ceccarelli; Simona M. ; et al. | 2015-09-17 |
| Substituted 1,6-naphthyridines App 20150252044 - Ceccarelli; Simona M. ; et al. | 2015-09-10 |
| Piperazino[1,2-a]indol-1-ones And [1,4]diazepino[1,2-a]indol-1-one App 20150246922 - Ceccarelli; Simona M. ; et al. | 2015-09-03 |
| Benzimidazoles As Cns Active Agents App 20150203472 - Ceccarelli; Simona M. ; et al. | 2015-07-23 |
| Conversion Of Somatic Cells To Induced Reprogrammed Neural Stem Cells (irnscs) App 20140051171 - CHRISTENSEN; KLAUS ; et al. | 2014-02-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 